CTRI/2024/04/066088尚未招募不适用
Lower Urinary Tract Dysfunction in Childhood Cancer Survivors - A Prospective Study
Swathi PM1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2024年4月30日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 92
- 试验地点
- 1
- 主要终点
- Association between chemotherapeutic agents and their cumulative dose with development of LUTDS
研究概览
简要总结
Chemotherapeutic agents commonly used in childhood cancer therapy may also cause long-term adverse effects, including lower urinary tract dysfunction (LUTD). LUTD can impact bladder function and lead to urinary incontinence, frequency, urgency, or difficulty in voiding. Despite several studies reporting a high prevalence of LUTD in childhood cancer survivors, the risk factors and optimal management strategies are not fully understood. This study aims to prospectively evaluate the prevalence, severity, risk factors, and management strategies of LUTD in childhood cancer survivors.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 5.00 Year(s) 至 18.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Survivors of childhood cancer 2.Age ≥ 5 years 3.Parents/guardians providing informed consent.
排除标准
- •1.Survivors with congenital Genito urinary malformations, Genetic syndromes, spinal defects, and neurologic disorder 2.Parents who refuse to consent.
结局指标
主要结局
Association between chemotherapeutic agents and their cumulative dose with development of LUTDS
时间窗: 6 months
次要结局
- assessing the risk factors for LUTD in cancer survivor children on chemotherapy(6 months)
研究者
Swathi PM
Kasturba Medical College Manipal
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization MicroscopyNCT07313878University of Erlangen-Nürnberg Medical School30
尚未招募
不适用
Adverse effects on adrenal gland in cancer patients after chemotherapyCTRI/2024/05/066876Maulana Azad Medical College50
尚未招募
不适用
A Phase 3, Open label, Randomized and Controlled Study of Disitamab Vedotin with Pembrolizumab Versus platinum containing chemotherapy in participants with Urothelial cancer that Expresses HER2 that has spread through the body or spread near where it started.CTRI/2025/07/091091Seagen Inc., a wholly owned subsidiary of Pfizer400
尚未招募
不适用
Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomABladder CancerNCT07413523Istituto Clinico Humanitas44
已完成
不适用
A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder CancerNCT07386847Pfizer1